Split History
MYGN split history picture
Myriad Genetics (MYGN) has 2 splits in our MYGN split history database. The first split for MYGN took place on September 12, 2000. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. MYGN's second split took place on March 26, 2009. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Myriad Genetics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the MYGN split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Myriad Genetics shares, starting with a $10,000 purchase of MYGN, presented on a split-history-adjusted basis factoring in the complete MYGN split history. MYGN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/02/2012
End date: 09/30/2022
Start price/share: $27.86
End price/share: $19.08
Dividends collected/share: $0.00
Total return: -31.51%
Average Annual Total Return: -3.71%
Starting investment: $10,000.00
Ending investment: $6,851.91
Years: 10.00
Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology. According to our MYGN split history records, Myriad Genetics has had 2 splits.
Date Ratio
09/12/20002 for 1
03/26/20092 for 1
MYGN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MYL Split History
MYMD Split History
MYO Split History
NATR Split History
NAVB Split History
NBS Split History
NBY Split History
NEOG Split History
NERV Split History
NMRD Split History

Also explore: MYGN shares outstanding history

Email EnvelopeFree MYGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

American Virtual Cloud Technologies, Inc. (AVCT)
Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

MYGN Insider Buying

MYGN Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.